Ribosome-display technology: applications for directed evolution of functional proteins

Drug Discovery Today

Volumn 11, Issue 19-20, 2006, Pages 911-916

  Yan, Xianghua ^a,b   Xu, Zirong ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADALIMUMAB; ALEMTUZUMAB; ARGINYLGLUTAMINYLGLUTAMYLARGINYLSERYLSERYLLEUCYLSERYLLYSYLPROLYLVALYLVALINE; BASILIXIMAB; BEVACIZUMAB; CETUXIMAB; COMPLEMENTARY DNA; DACLIZUMAB; EFALIZUMAB; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; INFLIXIMAB; MONOCLONAL ANTIBODY; NATALIZUMAB; OKT 3; OMALIZUMAB; PALIVIZUMAB; PEPTIDE LIBRARY; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANTIGEN BINDING; BACTERIAL INFECTION; BINDING AFFINITY; BIOTECHNOLOGY; CANCER IMMUNOTHERAPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOLUTION; GENE AMPLIFICATION; IMMUNE RESPONSE; IMMUNOGENICITY; MEDICINE; MOLECULAR EVOLUTION; MUTATION; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUALITATIVE ANALYSIS; REVIEW; RIBOSOME; SALMONELLA ENTERICA; TECHNOLOGY;

ANIMALS; DIRECTED MOLECULAR EVOLUTION; HUMANS; PROTEIN ENGINEERING; PROTEINS; RIBOSOMES;

EID: 33748904554     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2006.08.012     Document Type: Review

References (47)

1. Ross J.S., et al. Anticancer antibodies. Am. J. Clin. Pathol. 119 (2003) 472-485
2. Valle R.P., and Jendoubi M. Antibody-based technologies for target discovery. Curr. Opin. Drug Discov. Devel. 6 (2003) 197-203
3. Russeva M.G., and Adams G.P. Radioimmunotherapy with engineered antibodies. Expert Opin. Biol. Ther. 4 (2004) 217-231
4. Winter G., et al. Making antibodies by phage display technology. Annu. Rev. Immunol. 12 (1994) 433-455
5. Georgiou G., et al. Display of heterologous proteins on the surface of microorganisms: from the screening of combinatorial libraries to live recombinant vaccines. Nat. Biotechnol. 15 (1997) 29-34
6. Shusta E.V., et al. Biosynthetic polypeptide libraries. Curr. Opin. Biotechnol. 10 (1999) 117-122
7. Mattheakis L.C., et al. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9022-9026
8. Hanes J., and Plückthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4937-4942
9. He M., and Taussig M.J. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibodies combining sites. Nucleic Acids Res. 25 (1997) 5132-5134
10. Roberts R.W., and Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12297-12302
11. Schaffitzel C., et al. Ribosome display: an in vitro method for selection and evolution of antibodies from libraries. J. Immunol. Methods 231 (1999) 119-135
12. Gersuk G.M., et al. High-affinity peptide ligands to prostate-specific antigen identified by polysome selection. Biochem. Biophys. Res. Commun. 232 (1997) 578-582
13. Fjällman T., and Hall J.C. Antibody engineering-a valuable asset in preventing closed environment epidemics. Acta Astronaut. 57 (2005) 81-88
14. Moghaddam A., et al. Selection and characterisation of recombinant single-chain antibodies to the hapten Aflatoxin-B1 from naïve recombinant antibody libraries. J. Immunol. Methods 254 (2001) 169-181
15. Zhou B., et al. Human antibodies against spores of the genus Bacillus: a model study for detection of and protection against anthrax and the bioterrorist threat. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5241-5246
16. Moghaddam A., et al. Identification of scFv antibody fragments that specifically recognise the heroin metabolite 6-monoacetylmorphine but not morphine. J. Immunol. Methods 280 (2003) 139-155
17. Vaughan T.J., et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat. Biotechnol. 14 (1996) 309-314
18. Thom G., et al. Probing a protein-protein interaction by in vitro evolution. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7619-7624
19. He M., et al. Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display. J. Immunol. Methods 231 (1999) 105-117
20. He M., et al. Production of human single-chain antibodies by ribosome display. Methods Mol. Biol. 248 (2004) 177-189
21. Hanes J., et al. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14130-14135
22. Hanes J., et al. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved. by ribosome display. Nat. Biotechnol. 18 (2000) 1287-1292
23. Alimov A.P., et al. Cell-free synthesis and affinity isolation of proteins on a nanomole scale. Biotechniques 28 (2000) 338-344
24. Jackson A.M., et al. Cell-free protein synthesis for proteomics. Brief. Funct. Genomic Proteomic 2 (2004) 308-319
25. Ramachandiran V., et al. Expression of different coding sequences in cell-free bacterial and eukaryotic systems indicates translational pausing on E. coli ribosome. FEBS Lett. 482 (2000) 185-188
26. Hanes J., et al. Comparison of Escherichia coli and rabbit reticulocyte ribosome display systems. FEBS Lett. 450 (1999) 105-110
27. Pandey A., and Mann M. Proteomics to study genes and genomes. Nature 405 (2000) 837-846
28. He M., and Taussig M. Single step generation of protein arrays from DNA by cell-free expression and in situ immobilisation (PISA method). Nucleic Acids Res. 29 (2001) e73
29. Taussig M., et al. ARM complexes for in vitro display and evolution of antibody combining sites. In: Shepherd P., and Dean C. (Eds). Monoclonal Antibodies: A Practical Approach (2000), Oxford University Press, Oxford 91-109
30. Shimizu Y., et al. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19 (2001) 751-755
31. Lamla T., and Erdmann V.A. Searching sequence space for high affinity binding peptides using ribosome display. J. Mol. Biol. 329 (2003) 381-388
32. Coia G., et al. Panning and selection of proteins using ribosome display. J. Immunol. Methods 254 (2001) 191-197
33. Weichhart T., et al. Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect. Immun. 71 (2003) 4633-4641
34. Wu H.Y., et al. Functional selection of a type IV pili-binding peptide that specifically inhibits Salmonella Typhi adhesion to/invasion of human monocytic cells. Peptides 26 (2005) 2057-2063
35. Yan X.H., and Xu Z.R. Production of human single-chain variable fragment (scFv) antibody specific for digoxin by ribosome display. Indian J. Biochem. Biophys. 42 (2005) 350-357
36. Amstutz P., et al. In vitro display technologies: novel developments and applications. Curr. Opin. Biotechnol. 12 (2001) 400-405
37. Amstutz P., et al. In vitro selection for catalytic activity with ribosome display. J. Am. Chem. Soc. 124 (2002) 9396-9403
38. Lamla T., and Erdmann V.A. In vitro selection of other proteins than antibodies by means of ribosome display. FEBS Lett. 502 (2001) 35-40
39. Binz H.K., et al. High-affinity binders selected from designed ankyrin repeat protein libraries. Nat. Biotechnol. 22 (2004) 575-582
40. Nygren P.A., and Uhlén M. Scaffolds for engineering novel binding sites in proteins. Curr. Opin. Struct. Biol. 7 (1997) 463-469
41. Skerra A. Engineered protein scaffolds for molecular recognition. J. Mol. Recognit. 13 (2000) 167-187
42. Irving R.A., et al. Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J. Immunol. Methods 248 (2001) 31-45
43. Zahnd C., et al. Directed in vitro evolution and crystallographic analysis of a peptide binding single chain antibody fragment (scFv) antibody with low picomolar affinity. J. Biol. Chem. 279 (2004) 18870-18877
44. Jermutus L., et al. Tailoring in vitro evolution for protein affinity or stability. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 75-80
45. Wang X.B., et al. A new approach for rapidly reshaping single-chain antibody in vitro by combining DNA shuffling with ribosome display. J. Biochem. (Tokyo) 136 (2004) 19-28
46. Douthwaite J.A., et al. An improved method for an efficient and easily accessible eukaryotic ribosome display technology. Protein Eng. Des. Sel. 19 (2006) 85-90
47. Reichert J.M., et al. Monoclonal antibody successes in the clinic. Nat. Biotechnol. 23 (2005) 1073-1078